News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
347,020 Results
Type
Article (14781)
Company Profile (70)
Press Release (332169)
Multimedia
Podcasts (9)
Webinars (5)
Section
Business (104220)
Career Advice (474)
Deals (21530)
Drug Delivery (21)
Drug Development (44443)
Employer Resources (66)
FDA (8379)
Job Trends (9414)
News (180101)
Policy (18788)
Tag
Academia (1743)
Academic (1)
Accelerated approval (4)
Adcomms (5)
Allergies (40)
Alliances (22132)
ALS (36)
Alzheimer's disease (652)
Antibody-drug conjugate (ADC) (39)
Approvals (8423)
Artificial intelligence (71)
Autoimmune disease (15)
Automation (6)
Bankruptcy (194)
Best Places to Work (8626)
BIOSECURE Act (4)
Biosimilars (34)
Biotechnology (50)
Bladder cancer (53)
Brain cancer (14)
Breast cancer (150)
Cancer (1226)
Cardiovascular disease (87)
Career advice (410)
Career pathing (4)
CAR-T (105)
Cell therapy (237)
Cervical cancer (11)
Clinical research (36028)
Collaboration (340)
Compensation (184)
Complete response letters (8)
COVID-19 (2824)
CRISPR (13)
C-suite (102)
Cystic fibrosis (44)
Data (1452)
Decentralized trials (2)
Denatured (4)
Depression (25)
Diabetes (127)
Diagnostics (3914)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (46)
Drug pricing (15)
Drug shortages (8)
Duchenne muscular dystrophy (46)
Earnings (49203)
Editorial (16)
Employer branding (5)
Employer resources (57)
Events (52685)
Executive appointments (318)
FDA (9151)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (282)
Gene editing (41)
Generative AI (4)
Gene therapy (131)
GLP-1 (314)
Government (3417)
Grass and pollen (1)
Guidances (143)
Healthcare (12704)
Huntington's disease (9)
IgA nephropathy (15)
Immunology and inflammation (59)
Indications (16)
Infectious disease (2908)
Inflammatory bowel disease (81)
Inflation Reduction Act (2)
Influenza (39)
Intellectual property (65)
Interviews (84)
IPO (11638)
IRA (6)
Job creations (1150)
Job search strategy (356)
Kidney cancer (5)
Labor market (12)
Layoffs (174)
Leadership (6)
Legal (3814)
Liver cancer (45)
Lung cancer (180)
Lymphoma (104)
Machine learning (4)
Management (28)
Manufacturing (122)
MASH (50)
Medical device (7371)
Medtech (7374)
Mergers & acquisitions (10279)
Metabolic disorders (325)
Multiple sclerosis (45)
NASH (6)
Neurodegenerative disease (29)
Neuropsychiatric disorders (5)
Neuroscience (890)
NextGen: Class of 2025 (4684)
Non-profit (3257)
Now hiring (4)
Obesity (157)
Opinion (75)
Ovarian cancer (51)
Pain (43)
Pancreatic cancer (53)
Parkinson's disease (70)
Partnered (7)
Patents (140)
Patient recruitment (40)
Peanut (19)
People (28228)
Pharmaceutical (16)
Pharmacy benefit managers (6)
Phase I (10761)
Phase II (15728)
Phase III (12978)
Pipeline (1021)
Policy (52)
Postmarket research (1240)
Preclinical (4175)
Press Release (25)
Prostate cancer (60)
Psychedelics (10)
Radiopharmaceuticals (94)
Rare diseases (190)
Real estate (2419)
Recruiting (28)
Regulatory (12869)
Reports (16)
Research institute (1562)
Resumes & cover letters (65)
Rett syndrome (5)
RNA editing (1)
RSV (26)
Schizophrenia (35)
Series A (38)
Series B (22)
Service/supplier (7)
Sickle cell disease (32)
Special edition (9)
Spinal muscular atrophy (69)
Sponsored (12)
Startups (1371)
State (1)
Stomach cancer (2)
Supply chain (23)
Tariffs (11)
The Weekly (5)
Vaccines (594)
Venture capitalists (14)
Weight loss (75)
Women's health (15)
Worklife (5)
Date
Today (106)
Last 7 days (603)
Last 30 days (1584)
Last 365 days (17381)
2025 (6135)
2024 (19050)
2023 (22599)
2022 (30957)
2021 (35415)
2020 (35793)
2019 (37697)
2018 (23586)
2017 (14343)
2016 (12483)
2015 (16117)
2014 (10938)
2013 (8093)
2012 (9060)
2011 (9951)
2010 (8572)
Location
Africa (300)
Alabama (30)
Alaska (3)
Arizona (77)
Arkansas (4)
Asia (20158)
Australia (2683)
California (3529)
Canada (871)
China (228)
Colorado (171)
Connecticut (153)
Delaware (84)
Europe (40460)
Florida (649)
Georgia (127)
Idaho (23)
Illinois (300)
India (13)
Indiana (180)
Iowa (8)
Japan (90)
Kansas (64)
Kentucky (6)
Louisiana (4)
Maine (44)
Maryland (454)
Massachusetts (2493)
Michigan (103)
Minnesota (179)
Missouri (30)
Montana (7)
Nebraska (12)
Nevada (41)
New Hampshire (48)
New Jersey (1219)
New Mexico (3)
New York (1041)
North Carolina (455)
North Dakota (5)
Northern California (1585)
Ohio (82)
Oklahoma (3)
Oregon (7)
Pennsylvania (856)
Puerto Rico (8)
Rhode Island (14)
South America (491)
South Carolina (14)
Southern California (1378)
Tennessee (52)
Texas (433)
United States (13191)
Utah (122)
Virginia (72)
Washington D.C. (27)
Washington State (361)
West Virginia (2)
Wisconsin (19)
347,020 Results for "19".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
May 8, 2025
·
2 min read
·
Tristan Manalac
Vaccines
After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’
The FDA is asking Novavax for a non-mandatory postmarketing commitment to produce additional clinical data for its investigational COVID-19 vaccine.
April 24, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by various regulatory roadblocks.
April 29, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Pulls Funding for GeoVax’s Next-Gen COVID-19 Vaccine
GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb development.
April 17, 2025
·
2 min read
·
Tristan Manalac
Earnings
Novavax Sales Jump 600% YoY as COVID-19 Vaccine Still in Limbo at FDA
After more than a month of speculation over how the FDA will rule on Novavax’s application for an updated formulation of its COVID-19 shot, CEO John Jacobs said on the company’s Q1 earnings call: “When we have it, we’ll have it. Until then, we don’t have it.”
May 8, 2025
·
3 min read
·
Heather McKenzie
FDA
FDA Misses Review Deadline for Novavax’s COVID-19 Shot, Days After Marks’ Resignation
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1, but the agency’s principal deputy commissioner intervened.
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lung Immune Cell Type “Quietly” Controls Inflammation in COVID-19
April 28, 2025
·
5 min read
Press Releases
Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY
May 8, 2025
·
11 min read
Government
COVID-19 Critic Marty Makary Is Trump’s Likely Pick for FDA Top Post
Makary is a pancreatic surgeon at Johns Hopkins who became known for battling medical mistakes and in recent years has been an outspoken critic of COVID-19 policies.
November 21, 2024
·
2 min read
·
Tristan Manalac
Policy
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children:
Politico
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which recommends one dose for children and adolescents only if they have comorbidities.
April 23, 2025
·
3 min read
·
Tristan Manalac
1 of 34,702
Next
